Plasma CHI3L1 expression was particularly associated with poor survival in CCA patients (HR = 2.117, 1.027–4.363, p = 0.038, HR = 1.642, 0.780–3.455, p = 0.192) [110]. This evidence concerns the gene CHI3L1 and cholangiocarcinoma.